Volume 13, Number 10—October 2007
Global Poverty and Human Development
Schistosoma hematobium and S. mansoni among Children, Southern Sudan
We conducted a survey of schistosomiasis among schoolchildren in 2 villages in Southern Sudan. In Lui (West Equatoria region), prevalence of Schistosoma mansoni infection was 51.5%; no cases of S. hematobium infection were detected. In Nyal (Upper Nile region), prevalence of S. hematobium infection was 73% and S. mansoni infection, 70%.
Schistosomiasis is a major communicable disease of public health and socioeconomic importance in the developing world. Both Schistosoma hematobium and S. mansoni are present in Sudan, a war-torn country with a population of ≈6 million persons and one of the world’s most underdeveloped regions. Risk for schistosomiasis in Sudan is widespread, especially in the major irrigation systems in the Gezira area between the Blue and White Nile Rivers.
Early reports stated that schistosomiasis is endemic in southern provinces, but few sustained surveys have been conducted, particularly during the years overwhelmed by the civil war, and recent data on prevalence rates are lacking (1–3,5–10). We therefore conducted an epidemiologic survey in 2 villages in Southern Sudan.
This investigation was a cross-sectional study conducted in 2 separate regions of Southern Sudan from August through October 2002 (rainy season). The study population was recruited from the only primary schools in the village of Lui (Mundri County), West Equatoria Region, and from 3 randomly selected primary schools in the district of Nyal (for a total of 4 schools), Upper Nile Region, 40 km west of the Nile River (Figure). In 2006, an estimated 740,000 persons lived in the West Equatoria region, while an estimated 221,667 persons lived in Mundri County. An estimated 11,500–15,000 persons lived in Nyal village. The ecologic situation (rain, presence of water bodies, population density) and the presence of sanitation structures are homogenously distributed in Nyal District, and the populations of the schools we selected were representative of the parasitologic situation in this area. Lui has an estimated population of 7,000–9,000 persons and a primary school only.
To assess the prevalence of schistosomiasis, we conducted a survey of stool and urine samples as recommended by the World Health Organization (WHO) (11). A sample of 200–250 children in each ecologically homogenous area was considered adequate to evaluate prevalence and intensity of Schistosoma infection in a disease-endemic area. Before the onset of the study, information meetings were held with the school staff. Schoolchildren were asked to provide a stool sample and at least 10 mL of urine. Consent was obtained directly from the children (or parents or teachers) before specimen collection. The study was part of the routine investigations conducted by the Sudan Ministry of Health and WHO to provide adequate treatment to the children in the area. Because the surveyed children were not exposed to any risk (they only provided stool and urine samples), no special approval was requested.
Specimens were collected at school and brought to the laboratory, where they were prepared and interpreted within 24 hours. This procedure was repeated over 2 days in each village surveyed. Urine samples were tested for S. hematobium infection by using the Urine Filtration Kit (Vestergaard-Frandsen, Nairobi, Kenya) provided by WHO. Fecal specimens were tested for S. mansoni infection by using the Kato Katz semiquantitative method (11,12). Infections were classified as high intensity if results were >50 eggs of S. hematobium per 10 mL of urine or at least 400 eggs of S. mansoni per gram of feces. Because, for technical reasons, urine and stool specimens were collected on separate days, we have no data on dual S. hematobium and S. mansoni infection.
Urine specimens were obtained from 400 children, 200 in each village; fecal specimens were obtained from 400 children, 200 in each village. The age range was 8–12 years; 75% of those who provided samples were boys. The disparity between the sexes is probably related to more unwillingness of the girls to provide urine or fecal specimens.
The prevalence and intensity of S. hematobium and of S. mansoni, by geographic area, are shown in the Table. Though the prevalence was higher for girls than for boys, these differences were not statistically significant by χ2 test (data not shown). As a consequence of the high prevalence of schistosomiasis, praziquantel (40 mg/kg) treatment was offered to all children in the surveyed schools.
Most epidemiologic studies regarding schistosomiasis in Sudan have been carried out in the Gezira-Managil area and in other central or northern areas of economic importance, while relatively few studies have been conducted in other parts of the country. Our study was conducted in 2 ecologically different areas in Southern Sudan. The West Equatoria region is a savannah area, topographically and ethnographically homogeneous with the bordering regions of Uganda, characterized by a prevalence of intestinal bilharziasis (8). The Upper Nile region is a swampy area and has been considered by the Sudanese authorities as being nonendemic for bilharziasis (3,8).
The long-running civil war has overshadowed Southern Sudan’s recent history and devastated social and health services. Updated epidemiologic data are thus lacking, and most epidemiologic reports from these areas are scattered, incomplete, and outdated (1930–1970) (1–10). Data from annual reports of the Sudan Medical service in 1939–1949 and from other published or unpublished sources indicated that S. mansoni and S. hematobium were found in 1.9% and 2.5% of specimens in the Upper Nile region and in 4.9% and 0.25% of specimens in the Bahr El Ghazal region (close to the Northern Sudan border); in the West Equatoria region, the prevalence of S. mansoni–positive specimens has been reported as high as 44.3%, but no specimen was positive for S. hematobium (3,8). These data were based mainly on routine examination of urine and stools in hospitals and dispensaries. Subsequently, Amin and Omer suggested a 4.8%–6.8% prevalence of S. mansoni infection and a 0.4%–44% prevalence of S. hematobium infection in different areas of Southern Sudan (9).
Since the 1970s, few observations on the prevalence of schistosomiasis in southern Sudan have been made. Magambo et al. in 1998 reported a S. mansoni prevalence of 2.2% among children in 2 primary schools in the East Equatoria region, very close to the Ugandan border (10). A report conducted in the early 1990s in Juba (the largest and most developed town in Southern Sudan under the Northern government control) showed that 66% of refugees were harboring intestinal helminths, and in 26% of cases, S. mansoni (13). Data from Rhino camp, one of the major Ugandan camps accommodating Southern Sudanese refugees, showed a prevalence of S. mansoni as high as 77.8% (14). This potential impact of population mobility on the transmission of schistosomiasis should be taken into consideration. Actually, the January 2005 peace agreement between Khartoum and the Sudan People’s Liberation Movement is expected to trigger the return of half a million Sudanese who fled to nearby countries and the gradual resettlement of millions internally displaced. Increased efforts by the international community to help meet the basic needs of this rapidly growing population are urgently needed.
Our data confirm a high prevalence of S. mansoni infection in some areas in the West Equatoria region and show that both S. mansoni and S. hematobium are highly endemic in the Upper Nile region. The collected data facilitated schistosomiasis control interventions in the area. Mass distribution of praziquantel to all schoolchildren has been organized in the 2 districts since 2003.
When one considers the extremely high prevalence and the very low cost of the control measures (15), mass administration of praziquantel should be annually provided to the children in the resident population and to the children in the displaced population that will resettle to these areas as a consequence of peace agreements. These data also provide further evidence supporting the Centers for Disease Control and Prevention recommendation (available from www.cdc.gov/ncidod/dq/pdf/lost%20boys%20and%20girls%20presumptive%20treatment%20recommendations.pdf) that members of the Lost Boys and Girls of Sudan refugee group who have resettled in the United States and other Sudanese refugees receive presumptive therapy for schistosomiasis.
Dr Deganello is an infectious diseases specialist. At the time of this study, he was an infectious diseases field medical officer for WHO in Southern Sudan. He is currently completing postgraduate training in medical radiology at the University of Verona. His research interests include tropical diseases.
We thank Matteo Pinto and Claudia Rimondo for assistance in preparing the manuscript.
This study was supported in part by WHO.
- Cruikshank A. Tropical diseases of South Sudan: their distribution and significance. East Afr Med J. 1936;13:172–7.
- Hassan AM, Satir AA, Ahmed MA, Omer A. The pathology of schistosomiasis in Sudan. Trop Geogr Med. 1977;29:56–64.
- Ayad N. Bilharziasis survey in British Somaliland, Eritrea, Ethiopia, Somalia, the Sudan and Yemen. Bull World Health Organ. 1956;14:1–117.
- Archibald RG. The endemiology and epidemiology of schistosomiasis in the Sudan. J Trop Med Hyg. 1933;36:345–8.
- Omer AHS. Schistosomiasis in the Sudan: historical background and the present magnitude of the problem. Proceedings of the International Conference on Schistosomiasis, Cairo, Egypt. 1975;1978:121–32.
- Omer AH, Abdullah EA, Elhassan AM, Wasfi AM. Hycanthone trial in the treatment of Schistosoma mansoni infection in Sudan. J Trop Med Hyg. 1972;75:165–8.
- Kuntz RE, Lawless DK, Mansour NS. A cursory survey of the intestinal parasites of natives living in Southwest Sudan. Am J Trop Med Hyg. 1955;4:895–900.
- Ministry of Health of Sudan. Reports of the Sudan Medical Service for the years 1929–1948. Khartoum: The Ministry.
- Amin MA, Omer AHS. Schistosoma haematobium infection at El Ghorashi Dairy farm, Khartoum, Sudan. Sudan Med J. 1972;10:194–201.
- Magambo JK, Zeyhle E, Wachira TM. Prevalence of intestinal parasites among children in southern Sudan. East Afr Med J. 1998;75:288–90.
- Montresor A, Gyorkos T, Crompton DWT, Savioli L. Helminth control in school-age children. Geneva: World Health Organization; 2002. p. 19–20.
- World Health Organization. Basic laboratory methods in medical parasitology. Geneva: The Organization; 1991.
- Marnell F, Guillet A, Holland C. A survey of the intestinal helminths of refugees in Juba, Sudan. Ann Trop Med Parasitol. 1992;86:387–93.
- Loroni-Lakwo T, Odongo-Aginya EI, Schweigmann U, Schickerling S, Lindner D, Doehring-Schwerdtfeger E. Transmission of Schistosoma mansoni in Rhino Camp, Uganda. East Afr Med J. 1994;71:165–6.
- World Health Organization. Prevention and control of schistosomiasis and soil transmitted helminthiasis. Report of a WHO Expert Committee. Technical Report Series 912. Geneva: The Organization; 2002.
- Figure. Location of the study areas in Southern Sudan: A) Western Upper Nile; B) West Equatoria Region, Mundri County (source: Centre for Development and Environment, University of Berne, Switzerland; available from...
- Table. Prevalence and intensity of Schistosoma mansoni and S. hematobium in 2 villages in Southern Sudan
Suggested citation for this article: Deganello R, Cruciani M, Beltramello C, Duncan O, Ovugi V, Montresor A. Schistosoma hematobium and S. mansoni among children, Southern Sudan. Emerg Infect Dis [serial on the Internet]. 2007 Oct [date cited]. Available from http://wwwnc.cdc.gov/eid/article/13/10/07-0356
Please use the form below to submit correspondence to the authors or contact them at the following address:
Mario Cruciani, Center of Preventive Medicine/HIV Outpatient Clinic, V. Germania, 20 – 37135 Verona, Italy;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: July 02, 2010
- Page last updated: July 02, 2010
- Page last reviewed: July 02, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)